416 related articles for article (PubMed ID: 32445664)
1. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
2. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
[No Abstract] [Full Text] [Related]
3. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
Hindilerden F; Yonal-Hindilerden I; Akar E; Kart-Yasar K
Thromb Res; 2020 Nov; 195():136-138. PubMed ID: 32688098
[No Abstract] [Full Text] [Related]
5. Anaphylactic shock following the diagnosis of coronavirus disease 2019.
Alvarez-Perea A; Baeza ML
Ann Allergy Asthma Immunol; 2020 Oct; 125(4):477-478. PubMed ID: 32745608
[No Abstract] [Full Text] [Related]
6. COVID-19-associated immune thrombocytopenia.
Bomhof G; Mutsaers PGNJ; Leebeek FWG; Te Boekhorst PAW; Hofland J; Croles FN; Jansen AJG
Br J Haematol; 2020 Jul; 190(2):e61-e64. PubMed ID: 32420612
[No Abstract] [Full Text] [Related]
7. Lessons from the Italian COVID-19 frontline.
Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
[No Abstract] [Full Text] [Related]
8. A NET-thrombosis axis in COVID-19.
Hidalgo A
Blood; 2020 Sep; 136(10):1118-1119. PubMed ID: 32882018
[No Abstract] [Full Text] [Related]
9. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
10. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
11. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Loscocco GG
Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
[No Abstract] [Full Text] [Related]
12. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
Takami A
Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
[No Abstract] [Full Text] [Related]
13. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
14. COVID-19 patient with immune thrombocytopenic purpura.
Kewan T; Almhana F; Schwartzman L; Daw H; Haddad A
Int J Lab Hematol; 2020 Dec; 42(6):e260-e262. PubMed ID: 32786138
[No Abstract] [Full Text] [Related]
15. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
Hanley B; Roufosse CA; Osborn M; Naresh KN
Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
[No Abstract] [Full Text] [Related]
16. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
Bishop MR
Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
[No Abstract] [Full Text] [Related]
17. Severe immune thrombocytopenic purpura in critical COVID-19.
Lévesque V; Millaire É; Corsilli D; Rioux-Massé B; Carrier FM
Int J Hematol; 2020 Nov; 112(5):746-750. PubMed ID: 32613314
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
19. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Dragonetti D; Guarini G; Pizzuti M
Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
[No Abstract] [Full Text] [Related]
20. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
Ledford H
Nature; 2020 Apr; 580(7803):311-312. PubMed ID: 32273618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
